not tagged
not tagged
['nsclc', 'sclc', 'breast']
the second day of #esmo2022 has begun! this morning's sessions have explored fascinating topics including anti-body drug conjugates in patients with metastatic breast cancer and targeted therapies in nsclc. #esmo2022
EMJ is a publisher of open access eJournals for doctors & healthcare professionals. https://t.co/ss3noZANH3